Aim of the work: This work aimed to determine the frequency of subclinical memory dysfunction in a group of Malaysian systemic lupus erythematosus (SLE) patients and to study its relation to clinical characteristics, laboratory investigations and disease activity.
Introduction
Systemic lupus erythematosus (SLE) is a systemic chronic autoimmune disease that can affect all organs. The pathogenesis remains elusive and the etiology is multifactorial [1] . Several factors as cytokine overproduction [2, 3] , oxidative stress [4] , matrix metalloproteinase [5] and apoptosis [6] play a considerable role in the development of SLE. The kidney is commonly involved signifying the value of regular screening for early and appropriate management [7] . Comorbidities as dyslipidemia and metabolic syndrome [8, 9] could lead to functional disability, impaired quality of life and significantly affect disease activity and damage.
Neurological manifestations are common among SLE patients and these are highly diverse and often have major prognostic consequences. One of the most prevalent neuropsychiatric SLE (NPSLE) manifestations is cognitive dysfunction [10] reported to be as high as 81% [11] , while compilation from multiple databases showed that it ranged between 21% and 67% [12] . The most common cognitive impairment in SLE patients is memory dysfunction [10, 13] . Memory dysfunction in SLE patients was found to be associated with multiple risk factors including antiphospholipid antibodies, consistent corticosteroid use, diabetes, higher depression score and lower education level [11] . A contribution of higher disease activity to the development of memory impairment has been reported [12] .
Memory functioning generally refers to the ability to retain learned information over time and is one of several primary domains of cognitive ability typically evaluated in the context of a comprehensive neuropsychological assessment [14, 15] . It is important to note that memory is typically viewed as a group of related abilities based on the duration of time that information is retained (short vs. Long term) and the content that is stored [15] [16] [17] . Furthermore, memory is also composed of multiple processes which include encoding, storage and retrieving which are typically linear in progression. Any defect in any of these steps will impair memory functioning and each of these must be assessed in order to provide a comprehensive understanding of a patient's memory functioning [15, 18] .
The Wechsler Memory Scale (WMS) is a battery of subtests frequently administered in a neuropsychological assessment [19] and is designed to evaluate multiple aspects of learning and memory. Since the first edition that was published in 1945 [20] , it has been repeatedly revised and updated to the current 4th edition (WMS-IV). Administration of this new edition in its entirety generates primary index scores for immediate and delayed memory as well as secondary indexes of visual working memory, auditory memory and visual memory [21] . In the 4th edition, only three out of seven subtests were retained from the previous version whereas the remaining four tests are new. There are no data as regards this vital aspect in our local SLE population. The aim of this study was to determine frequency of subclinical memory dysfunction in a group of Malaysian SLE patients and to study its relation to clinical characteristics, laboratory investigations and disease activity.
Patients and methods
This was a cross-sectional study which recruited SLE patients from both the Rheumatology and Nephrology/SLE clinics at the Universiti Kebangsaan Malaysia Medical Centre (UKMMC) (Grant: FF-260-2012) and not known to have history of neuropsychiatric lupus. The SLE patients fulfilled the American College of Rheumatology revised classification criteria [10] and were >18 years old. An SLE disease activity index-2000 (SLEDAI-2K) was calculated for the studied patients [22] . All patients were administered the Wechsler Memory Scale-4th edition UK version (WMS-IV UK ) questionnaire [23] by the researcher. This study was approved by the UKMMC Medical Research and Ethics Committee (MREC) with the research code, FF-260-2012 and all the included patients gave an informed consent.
The Wechsler Memory Scale-4th edition (WMS-IV) is an individually administered battery of tests designed to assess memory functioning in individuals aged 16-90 [23] . It is developed and published by Pearson Education Inc. It is organized into five main memory index scores: auditory, visual, visual working, immediate and delayed memory indices. These index scores are scaled on a metric mean of 100 ± 15. An index score of less than 90 in any main category is considered to be below normal, and defined as memory impairment.
Statistical analysis
Demographic data of participants were recorded and charted accordingly. Data were analyzed using SPSS version 20.0. All numerical data were subjected to normality testing using Kruskal-Wallis Analysis. Data were analyzed using nonparametric tests and expressed as median with interquartile range (IQR). For categorical data, chi-square with Yate's correction was used and for non-categorical data, Mann-Whitney U and Kruskal-Wallis tests were used. A p-value of 60.05 was considered significant.
Results
Fifteen SLE patients with a median age of 28 years (25-37 years), 14 females and 1 male with disease duration of 9.3 years (4.8-10 years) were included. The sociodemographic data, level of education and comorbidities of the patients are presented in Table 1 .
There was no association between overall memory dysfunction and duration of SLE, number of relapses, number of major systems involvement and SLEDAI-2K scores as shown in Table 2 . However, visual memory was influenced by disease duration (p = 0.016). The laboratory and serologic parameters of the memory impaired and non-impaired groups at the time of the study are summarized in Table 3 . However, the memory-impaired group did have a significantly lower serum thyroxine level (p = 0.027) albeit still within the normal range and TSH levels were normal.
The majority of the patients were on prednisolone; memory impaired group, 5/7 (71.4%) and non-impaired group, 7/8 (87.5%). Cumulative prednisolone dose was not different between the two study groups. There was no association found between memory dysfunction and the use of prednisolone. Cumulative numbers of agents used were similar between the two study groups.
The memory main sub-domain indices (auditory; visual, immediate and delayed indices) of the studied patients are presented in Table 4 . There were significant differences in 3 out of 4 memory sub-domains between the memory impaired compared to the non-impaired groups viz visual memory index (VMI) (p = 0.004), immediate memory index (IMI) (p = 0.009) and delayed memory index (DMI) (p = 0.012). Only the auditory memory index was not affected. There was a significant association between the auditory memory index (AMI) and the level of education ( Table 5 ). The other memory sub-domains were not affected. There was association between the memory indices sub-domain according to the number of systems involved (Table 5 ).
Discussion
Cognitive impairment is a well recognized feature of neuropsychiatric manifestation in SLE [11] . One of the major compo- nents in the cognitive process is memory. Memory per se is an integration of four major sub-domains i.e. auditory, visual, immediate and delayed memory. Memory function requires simultaneous multistep processes of these sub-domains and any disruption of these steps may cause impairment of memory [24] .
Previous studies have focused on overall cognitive function rather than the detailed components of memory [25, 26] . The prevalence of memory dysfunction in SLE was reported to range from 43% to 75% [27] . A small simple-to-administer memory assessment tool would be invaluable as regards the detailed study of the subdomains. Hence we conducted this pilot study using the newly updated WMS-IV memory assessment tool. WMS-IV is known to be more comprehensive and simple-to-use battery of memory tests [23] . The WMS-IV has not been used among the lupus population, although it was widely used in neuropsychological assessment [28] . There are no reference ranges for the memory indices in our local SLE population. The reported study is small and employed one or more combinations of various neuropsychological batteries of tests to assess overall cognitive function [20] . Using this tool, a frequency of 46.7% memory dysfunction was found in the Malaysian SLE population which is consistent with other results [27] .
There were no associations between memory dysfunction with the age or level of education of the SLE patients. These findings concur with those reported by Maneeton et al. and Olazara´n et al. [29, 30] . Of interest, the age and level of education of the subjects in Olazaran et al. study were comparable to those of ours [30] . In contrast, Murray et al. reported that a low education level was one of the predictors of memory dysfunction in their SLE population [31] and significantly associated with declining cognitive function [32] . Although the overall memory function and education levels were not associated in this study, auditory memory index (AMI) scores were significantly lower in those with a lower education level (p = 0.025). This was in agreement with the results of others [30, 33, 34] . Thus auditory memory appears to be the earliest memory sub-domain to be affected in SLE patients with lower education levels. Interestingly, serum thyroxine levels showed a significant association with overall memory impairment in SLE. Hypothyroidism has been associated with memory deficits [35] , although to date, there are no reported associations between these two entities in SLE. Whether thyroxine supplementation is indicated or useful in reversing this subtle memory dysfunction can only be speculative at present.
There were markedly lower scores in three of the four memory sub-domains. This involvement of multiple memory subdomains is consistent with those results of others [28] . Although these have focused on overall cognitive function rather than memory dysfunction per se.
Disease duration, number of relapses, disease activity as measured by SLEDAI-2K and cumulative number of systems involvement did not show any association with the overall memory performance in our patients. These findings are similar to those reported by others [36, 37] . Data concerning memory dysfunction and SLE disease activity are highly controversial. Others have concentrated on the overall cognitive function in relation to SLE disease activity. Fisk et al. reported an association between cognitive decline and higher SLEDAI scores [38] . In contrast, Carbotte et al. found no relation [39] . Skeel et al. also found no decline in the memory parameters of 17 SLE patients with cognitive complaints [40] . However, all the above authors only measured the SLE-DAI score at the time of study which will not reflect true past disease activity whereas, we examined the current and worst SLEDAI-2K scores during the course of illness. This should have detected any past damage not hitherto recognized at the time of active disease. We too found no association between memory dysfunction and current or worst SLEDAI-2K scores. All memory sub-domains were also not associated with SLEDAI-2K.
It has been reported that the verbal (auditory) sub-domain was the most affected by SLE [30, 33, 34] . Cumulative number of system involvement, co-morbidities and number of immunomodulatory medications used were comparable between SLE patients with and without memory impairment. Disease duration influenced the visual memory. This association has not been previously reported in the literature. This may represent the early subclinical phase of memory dysfunction.
Corticosteroid dosage and cumulative dose did not impact the memory indices in our study population. There are conflicting data in the literature concerning the association between memory function and corticosteroid use. A strong association between consistent steroid use and the cognitive process has been reported [32] . Whereas others noted that only the daily prednisolone dosage affected cognitive function [29] . However other studies also failed to demonstrate any relation between steroid use and memory dysfunction [37, 39] . The underlying damage of the subtle memory processes due to the chronic relapsing-remitting nature of SLE will determine the cumulative corticosteroid exposure. The relationship between corticosteroid use in acute disease and during maintenance with corticosteroid dosage and cumulative dose is difficult to dissect. These probably interact in a complex manner depending on disease activity, duration, type and number of organ systems involved as well as accrued damage. Other immunomodulatory medications such as hydroxychloroquine and cyclophosphamide did not affect the patients' cognitive and memory functions [29] . Interestingly, a protective effect of aspirin on memory function in SLE patients has been reported [32] .
Regarding the study limitations, firstly, the number of patients included was low and it is noteworthy that the Wechsler Memory Tests took 1 h to be completed for each subject. Secondly there was no MRI brain done for all subjects including control. A negative history may not rule out neuropsychiatric lupus. Future longitudinal studies on a larger scale of patients are recommended to explore these interesting results and to include a wider population of healthy control to give a better estimate of the impairment in SLE patients. Considering more parameters in a regression analysis and including autoantibodies and SLE damage index would be more informative in future studies and help in detecting risk factors and to provide a comprehensive picture of the cumulative disease damage especially with regard to subtle memory dysfunction.
In conclusion there was a high prevalence of 'overall' memory dysfunction (46.7%) in our local SLE population. A current low serum thyroxine level was found to be a risk factor and this may be amenable to treatment. The cumulative dose of corticosteroids and other immunomodulatory medications were also not risk factors for 'overall' memory dysfunction. However, the memory impaired patients performed significantly poorer in 3 of the 4 memory sub-domains compared with the non-impaired group. Impairment of the visual memory sub-domain was associated with SLE disease duration whereas auditory memory dysfunction was associated with a lower level of education.
